The role of recombinant activated factor VII in obstetric hemorrhage

Current Opinion in Anaesthesiology

Volumn 25, Issue 3, 2012, Pages 309-314

  Ahonen, Jouni ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

coagulation; postpartum hemorrhage; recombinant factor VIIa

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8A; CALCIUM ION; COLLAGEN; D DIMER; FIBRIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HETASTARCH; PROTHROMBIN; PROTHROMBIN A; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ANTICOAGULATION; ARTIFICIAL EMBOLISM; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; COLLOID; CRYOPRECIPITATE; CRYSTALLOID; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG HALF LIFE; EARLY INTERVENTION; ENDOTHELIUM CELL; ERYTHROCYTE TRANSFUSION; FIBRIN CLOT; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; UTERINE ATONY; UTERINE TAMPONADE; VENOUS THROMBOEMBOLISM;

ADULT; ANTIFIBRINOLYTIC AGENTS; COLLOIDS; FACTOR VII; FEMALE; HUMANS; INFANT, NEWBORN; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS;

EID: 84861101031     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283532007     Document Type: Review

References (47)

1. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997;78:1463-1467.
2. ten Cate H, Bauer KA, Levi M, et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993;92:1207-1212.
3. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003;17:S1-S5.
4. Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998;9:S61-S65.
5. Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Semin Thromb Hemost 2006;32:77-85.
6. Ahonen J, Stefanovic V, Lassila R. Management of postpartum haemorrhage. Acta Anaesthesiol Scand 2010;54:1164-1178.
7. Clark CA, Vatsyayan R, Gopalakrishnan R, et al. Endothelial protein C receptor-mediated redistribution and tissue-level accumulation of pharmacologically administered recombinant human factor VIIa. 53rd ASH Annual Meeting and Exposition;, 12 December 2011; San Diego. Abstract number 532. This is an interesting abstract of a group that has investigated the endothelial protein C receptor-dependent mechanisms of rFVIIa, which may prolong the hemostatic effect of rFVIIa.
8. Moscardo F, Pérez F, de la Rubia J, et al. Successful treatment of severe intraabdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;113:174-176.
9. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening postpartum haemorrhage. Br J Anaesth 2005;94:592-595.
10. Hossain N, Shamsi T, Haider S, et al. Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstet Gynecol 2007;86:1200-1206.
11. Alfirevic Z, Elbourne D, Pavord S, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage. Obstet Gynecol 2007;110:1270-1278.
12. Ahonen J, Jokela R, Korttila K. An open nonrandomized study of recombinant activated factor VII in major postpartum haemorrhage. Acta Anaesthesiol Scand 2007;51:929-936.
13. Bouma LS, Bolte AC, van Geijn HP. Use of recombinant activated factor VII in massive postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2008;137:172-177.
14. Barillari G, Frigo MG, Casarotto M, et al. Use of recombinant activated factor VII in massive postpartum haemorrhage: data from the Italian registry. A multicentric observational study. Thromb Res 2009;124:e41-e47.
15. Phillips LE, McLintock C, Pollock W, et al. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand haemostasis registry. Anesth Analg 2009;109:1908-1915.
16. Kobayashi T, Nakabayashi M, Yoshioka A, et al. Recombinant activated factor VII (rFVIIa/Novoseven1) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. Int J Hematol 2011; DOI: 10.1007/s12185-011-0974-9.
17. Franchini M, Franchi M, Bergamini V, et al. A critical review of the use of recombinant factor VIIa in life-threatening obstetric postpartum haemorrhage. Semin Thromb Hemost 2008;34:104-112.
18. Franchini M, Franchi M, Bergamini V, et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol 2010;53:219-227. This is the largest systematic review on the use of rFVIIa in PPH, which included studies reporting more than 10 cases in the final analysis and presented data on 272 women.
19. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17:385-396.
20. Higgins JR, Walshe JJ, Darling MRN, et al. Hemostasis in the uteroplacental and peripheral circulations in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol 1998;179:520-526.
21. Epiney M, Boehlen F, Boulvain M, et al. D-dimer levels during delivery and the postpartum. J Thromb Haemost 2005;3:268-271.
22. Wojciechowski PJ, Samol N, Walker J. Coagulopathy in massive transfusion. Int Anesthesiol Clin 2005;43:1-20.
23. Gai M-Y, Wu L-F, Su Q-F, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multicenter, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004;112:154-157.
24. Mayur G, Purvi P, Ashoo G, Pankaj D. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study. J Obstet Gynecol India 2007;57:227-230.
25. Ducloy-Bouthors A-S, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011;15:R117. This is the first clinical trial on the use of tranexamic acid in the treatment of PPH.
26. Ferrer P, Roberts I, Sydenham E, et al. Antifibrinolytic agents in postpartum haemorrhage: a systematic review. BMC Pregnancy and Childbirth 2009;9:29-34.
27. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009;22:267-274.
28. Kozek-Langenecker S. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-660.
29. Westphal M, James MFM, Kozek-Langenecker S, et al. Hydroxyethyl starches. Anesthesiology 2009;111:187-202.
30. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905-917.
31. Mittermayr M, Streif W, Haas T, et al. Effect of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 2008;100:307-314.
32. Eugster M, Reinhart WH. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 2005;94:1213-1218.
33. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem 1992;267:24259-24263.
34. Blomback B, Carlsson K, Fatah K, et al. Fibrin in the human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 1994;75:521-538.
35. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogramin rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002;88:576-582.
36. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 2006;26:41-48.
37. Allen GA, Wolberg AS, Oliver JA, et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2004;2:402-413.
38. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography1: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005;49:222-231.
39. Macphail S, Talks K. Massive postpartum haemorrhage and management of disseminated intravascular coagulation. Curr Obstet Gynaecol 2004;14:123-131.
40. Thachil J, Toh C-H. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009;23:167-176.
41. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thrombost Haemost 2007;5:266-273.
42. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63:805-813.
43. Welsh A, McLintock C, Gatt S, et al. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008;48:12-16.
44. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 2007;16:40-49.
45. Lewis LR, Brunker P, Lemire SJ, et al. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage. Transfusion 2009;49:689-694. This is an excellent case study to show how rFVIIa is ineffective if there is a shortage of the basic components of the coagulation cascade such as fibrinogen.
46. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante-and postnatal risk factors for venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008;6:905-912.
47. Roderick P, Ferris G, Wilson K, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic review of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprohylaxis. Health Technol Assess 2005;9:1-78.